Search research articles
Contact Us
Filters
Showing results (1011-1020 of 1,158) with videos related to
Page
of 116
Sort By:
The Lancet. Respiratory Medicine
|
November 14, 2022
Rituximab versus intravenous cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease in the UK (RECITAL): a double-blind, double-dummy, randomised, controlled, phase 2b trial
Toby M Maher, Veronica A Tudor, Peter Saunders, et al.
Insights Into Imaging
|
October 25, 2017
Body composition determinants of radiation dose during abdominopelvic CT
Patrick D McLaughlin, Liam Chawke, Maria Twomey, et al.
The Lancet. Respiratory Medicine
|
October 3, 2025
Taladegib for the treatment of idiopathic pulmonary fibrosis (ENV-IPF-101): a multicentre, randomised, double-blind, placebo-controlled, phase 2a trial
T M Maher, J G Goldin, J Hood, et al.
Biorxiv : the Preprint Server for Biology
|
June 10, 2024
Association between mosaic loss of chromosome Y and pulmonary fibrosis susceptibility and severity
Dapeng Wang, Niran Hadad, Samuel Moss, et al.
BMJ Open Respiratory Research
|
February 11, 2026
Assessment of mosaic loss of chromosome Y in pulmonary fibrosis reveals limited association with susceptibility or disease severity
Dapeng Wang, Niran Hadad, Samuel Moss, et al.
American Journal of Respiratory and Critical Care Medicine
|
May 5, 2026
Deupirfenidone Compared with Pirfenidone and Placebo in Idiopathic Pulmonary Fibrosis (ELEVATE-IPF): a Phase 2b Randomized Placebo-Controlled Trial
Toby M Maher, Mark J Hamblin, Won-Ii Choi, et al.
Medrxiv : the Preprint Server for Health Sciences
|
May 4, 2026
Cross-ancestry evaluation of idiopathic pulmonary fibrosis genetic risk variants
Ritah Nabunje, Beatriz Guillen-Guio, Tamara Hernandez-Beeftink, et al.
BMJ Open
|
June 4, 2021
Muscle stimulation in advanced idiopathic pulmonary fibrosis: a randomised placebo-controlled feasibility study
Claire M Nolan, Suhani Patel, Ruth E Barker, et al.
The New England Journal of Medicine
|
May 19, 2025
Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis
Luca Richeldi, Arata Azuma, Vincent Cottin, et al.
AJNR. American Journal of Neuroradiology
|
January 8, 2021
Clinical, Imaging, and Lab Correlates of Severe COVID-19 Leukoencephalopathy
O Rapalino, A Pourvaziri, M Maher, et al.
Page
of 116
Search research articles
Search
Showing results (1011-1020 of 1,158) with videos related to
Sort By:
Page
of 116
The Lancet. Respiratory Medicine
|
November 14, 2022
Rituximab versus intravenous cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease in the UK (RECITAL): a double-blind, double-dummy, randomised, controlled, phase 2b trial
Toby M Maher, Veronica A Tudor, Peter Saunders, et al.
Insights Into Imaging
|
October 25, 2017
Body composition determinants of radiation dose during abdominopelvic CT
Patrick D McLaughlin, Liam Chawke, Maria Twomey, et al.
The Lancet. Respiratory Medicine
|
October 3, 2025
Taladegib for the treatment of idiopathic pulmonary fibrosis (ENV-IPF-101): a multicentre, randomised, double-blind, placebo-controlled, phase 2a trial
T M Maher, J G Goldin, J Hood, et al.
Biorxiv : the Preprint Server for Biology
|
June 10, 2024
Association between mosaic loss of chromosome Y and pulmonary fibrosis susceptibility and severity
Dapeng Wang, Niran Hadad, Samuel Moss, et al.
BMJ Open Respiratory Research
|
February 11, 2026
Assessment of mosaic loss of chromosome Y in pulmonary fibrosis reveals limited association with susceptibility or disease severity
Dapeng Wang, Niran Hadad, Samuel Moss, et al.
American Journal of Respiratory and Critical Care Medicine
|
May 5, 2026
Deupirfenidone Compared with Pirfenidone and Placebo in Idiopathic Pulmonary Fibrosis (ELEVATE-IPF): a Phase 2b Randomized Placebo-Controlled Trial
Toby M Maher, Mark J Hamblin, Won-Ii Choi, et al.
Medrxiv : the Preprint Server for Health Sciences
|
May 4, 2026
Cross-ancestry evaluation of idiopathic pulmonary fibrosis genetic risk variants
Ritah Nabunje, Beatriz Guillen-Guio, Tamara Hernandez-Beeftink, et al.
BMJ Open
|
June 4, 2021
Muscle stimulation in advanced idiopathic pulmonary fibrosis: a randomised placebo-controlled feasibility study
Claire M Nolan, Suhani Patel, Ruth E Barker, et al.
The New England Journal of Medicine
|
May 19, 2025
Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis
Luca Richeldi, Arata Azuma, Vincent Cottin, et al.
AJNR. American Journal of Neuroradiology
|
January 8, 2021
Clinical, Imaging, and Lab Correlates of Severe COVID-19 Leukoencephalopathy
O Rapalino, A Pourvaziri, M Maher, et al.
Page
of 116